Spire Wealth Management’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-100
Closed -$2K 2859
2022
Q1
$2K Hold
100
﹤0.01% 2427
2021
Q4
$3K Buy
+100
New +$2.86K ﹤0.01% 2736

Other funds holding CDMO

Spire Wealth Management's CDMO Position: Q2 2022 in Review

Spire Wealth Management sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q2 2022, closing a stake of 100 shares — an estimated $2K sold.

Spire Wealth Management first reported a position in CDMO in Q4 2021 and held it in 2 quarters. The position peaked at $3K in Q4 2021. 187 funds tracked by Wall St. Rank hold CDMO as of Q2 2022.

  • Spire Wealth Management reported no remaining Avid Bioservices, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Spire Wealth Management sold 100 Avid Bioservices, Inc. Common Stock shares in Q2 2022, an estimated $2K.
  • Spire Wealth Management first reported a position in Avid Bioservices, Inc. Common Stock in Q4 2021 and held it in 2 quarters.
  • Spire Wealth Management's Avid Bioservices, Inc. Common Stock position peaked at $3K in Q4 2021.
  • 187 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q2 2022.

Based on Spire Wealth Management's 13F filing for Q2 2022, filed 22 Jul 2022.